Ascelia Pharma AB (publ) (STO:ACE)
Sweden
· Delayed Price · Currency is SEK 3.000
+0.035 (1.18%)
At close: Dec 5, 2025
Ascelia Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 72.28 | 75.26 | 21.86 | 149.56 | 261.6 | 184.69 | Upgrade
|
| Cash & Short-Term Investments | 72.28 | 75.26 | 21.86 | 149.56 | 261.6 | 184.69 | Upgrade
|
| Cash Growth | -24.49% | 244.34% | -85.39% | -42.83% | 41.64% | 0.25% | Upgrade
|
| Other Receivables | 3.11 | 6.1 | 2.99 | 5.16 | 5.87 | 2.83 | Upgrade
|
| Receivables | 3.11 | 6.1 | 2.99 | 5.16 | 5.87 | 2.83 | Upgrade
|
| Prepaid Expenses | 1.04 | 0.61 | 0.66 | 0.79 | 0.96 | 0.53 | Upgrade
|
| Other Current Assets | 1.76 | 1.75 | 3.43 | 5.36 | 6.18 | 8.28 | Upgrade
|
| Total Current Assets | 78.18 | 83.72 | 28.94 | 160.87 | 274.61 | 196.32 | Upgrade
|
| Property, Plant & Equipment | 1.16 | 0.12 | 1.06 | 0.63 | 1.82 | 1.99 | Upgrade
|
| Other Intangible Assets | 57.07 | 57.08 | 57.07 | 57.07 | 57.06 | 57.06 | Upgrade
|
| Other Long-Term Assets | -0 | - | -0 | 0 | - | - | Upgrade
|
| Total Assets | 136.42 | 140.92 | 87.07 | 218.57 | 333.49 | 255.37 | Upgrade
|
| Accounts Payable | 7.25 | 4.73 | 1.53 | 15.88 | 6.15 | 3.88 | Upgrade
|
| Accrued Expenses | 12.62 | 12.73 | 8.52 | 19.66 | 16.34 | 12.98 | Upgrade
|
| Short-Term Debt | - | 25.23 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 0.89 | 0.17 | 0.88 | 0.29 | 1.1 | 0.82 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0.01 | - | Upgrade
|
| Other Current Liabilities | 0.97 | 19.11 | 1.64 | 1.69 | 1.51 | 0.67 | Upgrade
|
| Total Current Liabilities | 21.73 | 61.98 | 12.57 | 37.52 | 25.11 | 18.36 | Upgrade
|
| Long-Term Leases | 0.29 | - | 0.18 | 0.19 | 0.55 | 0.96 | Upgrade
|
| Other Long-Term Liabilities | -0 | - | - | -0 | - | - | Upgrade
|
| Total Liabilities | 22.01 | 61.98 | 12.74 | 37.71 | 25.66 | 19.32 | Upgrade
|
| Common Stock | 127.9 | 97.19 | 34.87 | 34.87 | 34.58 | 28.7 | Upgrade
|
| Additional Paid-In Capital | 771.37 | 721.75 | 678.75 | 678.75 | 678.83 | 493.73 | Upgrade
|
| Retained Earnings | -785.93 | -740.97 | -639.96 | -533.73 | -405.83 | -286.49 | Upgrade
|
| Comprehensive Income & Other | 1.06 | 0.97 | 0.67 | 0.97 | 0.25 | 0.12 | Upgrade
|
| Shareholders' Equity | 114.4 | 78.94 | 74.33 | 180.86 | 307.83 | 236.06 | Upgrade
|
| Total Liabilities & Equity | 136.42 | 140.92 | 87.07 | 218.57 | 333.49 | 255.37 | Upgrade
|
| Total Debt | 1.18 | 25.4 | 1.06 | 0.48 | 1.66 | 1.78 | Upgrade
|
| Net Cash (Debt) | 71.1 | 49.86 | 20.8 | 149.07 | 259.94 | 182.91 | Upgrade
|
| Net Cash Growth | 2.89% | 139.76% | -86.05% | -42.65% | 42.12% | -0.60% | Upgrade
|
| Net Cash Per Share | 0.67 | 0.92 | 0.62 | 4.28 | 7.89 | 6.96 | Upgrade
|
| Filing Date Shares Outstanding | 117.47 | 96.11 | 33.76 | 33.67 | 33.67 | 28.19 | Upgrade
|
| Total Common Shares Outstanding | 117.47 | 96.11 | 33.76 | 33.67 | 33.67 | 28.19 | Upgrade
|
| Working Capital | 56.45 | 21.74 | 16.37 | 123.35 | 249.51 | 177.96 | Upgrade
|
| Book Value Per Share | 0.97 | 0.82 | 2.20 | 5.37 | 9.14 | 8.37 | Upgrade
|
| Tangible Book Value | 57.33 | 21.87 | 17.25 | 123.79 | 250.77 | 179 | Upgrade
|
| Tangible Book Value Per Share | 0.49 | 0.23 | 0.51 | 3.68 | 7.45 | 6.35 | Upgrade
|
| Machinery | - | 0.6 | 0.6 | 0.6 | 0.6 | 0.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.